Abteilungsleiter at Epilepsiezentrum, Universitätsklinikum Freiburg, Germany
Prof. Dr. med. Andreas Schulze-Bonhage is a renowned neurologist and clinical neurophysiologist specializing in epilepsy research and treatment. As the Head of the Epilepsy Center at the University Hospital Freiburg, Germany, he leads a European Reference Center for pediatric and adult patients with the largest university-based presurgical program in Germany. With over 25 years of clinical experience, Dr. Schulze-Bonhage has made significant contributions to epilepsy research, including electrophysiological and imaging studies, seizure detection, and neuromodulatory approaches ¹.
Profile
scopus
🎓 Education
– *MD in Neuroanatomy*: Münster University, 1998 📚– *Studies in Human Medicine*: Münster University, 1981-1987 👨⚕️– *Habilitation (PhD)*: University of Freiburg, Germany, 2004 🎓
👨🔬 Experience
– *Head, Epilepsy Center*: University Hospital Freiburg, since 1998 🏥– *President, German Section of ILAE*: 2019-2021 💼– *International Delegate, German Section of ILAE*: since 2020 🌟– *Investigator PI*: > 50 pharmacological multicenter trials in epilepsy 🔬
🔍 Research Interest
– *Epilepsy Research*: electrophysiological and imaging studies, seizure detection, neuromodulatory approaches, and network analyses of the human brain 🧠– *Neuromodulation*: Vagus Nerve Stimulation, Deep Brain Stimulation, and Focal Cortex Stimulation for epilepsy treatment
Awards and Honors 🏆
– Although specific awards and honors are not listed in the provided information, Dr. Schulze-Bonhage’s leadership roles and memberships in esteemed organizations underscore his reputation as a respected figure in the global epilepsy community 🏆
📚 Publications
– Dynamic facial emotion recognition and affective prosody recognition in patients with temporal lobe epilepsy 🤖
– Ripple-locked coactivity of stimulus-specific neurons and human associative memory 🧠
– Outcome of Epilepsy Surgery in MRI-Negative Patients Without Histopathologic Abnormalities in the Resected Tissue 🏥
– Physiological and pathological neuronal connectivity in the living human brain based on intracranial EEG signals
Conclusion
Given Dr. Schulze-Bonhage’s extensive clinical experience, research leadership, international recognition, prolific research output, and editorial board memberships, he appears to be an outstanding candidate for the Best Researcher Award. His contributions to epilepsy research and treatment have likely improved the lives of countless patients, and his continued research endeavors will likely shape the future of epilepsy care.